Merck 2Q Revenues: $ $10.5 billion (+5%) 2Q Earnings: $1.7 billion (-12%) YTD Revenues: $20.5 billion (+6%) YTD Earnings: $2.5 billion (-30%) Comments: Pharmaceutical sales increased 6% in the quarter to $9.3 billion, driven by growth in oncology, vaccines and hospital acute care, partially offset by lower sales in virology and the ongoing impacts of the loss of market exclusivity for several products. KEYTRUDA sales were up 89% to $1.7 billion. JANUVIA sales were $1.5 billion, up 2%. GARDA...